Jean Rommelaere Selected Research

Jean Rommelaere Research Topics

Disease

52	Neoplasms (Cancer) 10/2021 - 05/2002
33	Infections 02/2022 - 05/2002
9	Glioma (Gliomas) 01/2016 - 03/2004
7	Adenocarcinoma 10/2021 - 04/2010
6	Virus Diseases (Viral Diseases) 02/2022 - 03/2004
6	Pancreatic Neoplasms (Pancreatic Cancer) 08/2017 - 01/2009
6	Neoplasm Metastasis (Metastasis) 08/2017 - 05/2002
4	Parvoviridae Infections (Parvovirus Infection) 02/2022 - 06/2009
4	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 02/2005
4	Brain Neoplasms (Brain Tumor) 01/2020 - 08/2010
4	Melanoma (Melanoma, Malignant) 01/2019 - 02/2004
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 12/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2017 - 10/2010
2	Carcinoma (Carcinomatosis) 07/2013 - 10/2010
2	Stomach Neoplasms (Stomach Cancer) 07/2012 - 01/2005
2	Liposarcoma 12/2008 - 08/2006
2	Wiskott-Aldrich Syndrome 08/2008 - 01/2005
2	Hemangiosarcoma (Angiosarcoma) 02/2004 - 05/2002
1	Vesicular Stomatitis 01/2021
1	Vaccinia 01/2021
1	Measles 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 10/2017
1	Disease Progression 08/2017
1	Leukemia 01/2017
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2017
1	Hyperplasia 02/2015
1	Herpes Simplex 01/2014
1	Peritoneal Neoplasms 11/2011

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 02/2022 - 10/2002
9	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 08/2005
6	Pharmaceutical PreparationsIBA 08/2017 - 01/2009
5	DNA (Deoxyribonucleic Acid)IBA 08/2010 - 02/2004
4	Viral ProteinsIBA 01/2018 - 09/2006
4	LigandsIBA 12/2017 - 02/2011
4	ChemokinesIBA 01/2017 - 05/2002
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2010
3	Therapeutic UsesIBA 12/2017 - 05/2004
3	Viral DNAIBA 10/2017 - 03/2003
3	Gemcitabine FDA Link 05/2014 - 01/2009
3	CytokinesIBA 01/2014 - 05/2002
3	Interleukin-2 (IL2)IBA 11/2012 - 12/2002
3	Neutralizing AntibodiesIBA 01/2010 - 05/2004
2	Peptides (Polypeptides)IBA 02/2022 - 04/2012
2	Nucleic AcidsIBA 10/2021 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
2	Cathepsin BIBA 12/2017 - 04/2007
2	AntibodiesIBA 01/2014 - 11/2011
2	Histone Deacetylase InhibitorsIBA 10/2013 - 10/2010
2	InterferonsIBA 11/2011 - 09/2006
2	GelsolinIBA 08/2008 - 01/2005
2	VaccinesIBA 06/2008 - 06/2007
1	Monoclonal AntibodiesIBA 02/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	ParaffinIBA 01/2020
1	Single-Stranded DNA (DNA, Single Stranded)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Immune Checkpoint ProteinsIBA 01/2019
1	Granzymes (Granzyme)IBA 01/2019
1	IpilimumabIBA 01/2019
1	NivolumabIBA 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2017
1	ciglitazoneIBA 12/2017
1	Death Domain ReceptorsIBA 12/2017
1	CaspasesIBA 12/2017
1	TNF-Related Apoptosis-Inducing LigandIBA 12/2017
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2017
1	ThiazolidinedionesIBA 12/2017
1	Rosiglitazone (Avandia)FDA Link 12/2017
1	Pioglitazone (Actos)FDA Link 12/2017
1	Gentian Violet (Violet, Crystal)FDA Link 10/2017
1	Codon (Codons)IBA 11/2016
1	Vaccine AdjuvantsIBA 08/2015
1	cyclonite (RDX)IBA 03/2015
1	CalreticulinIBA 05/2014
1	AlarminsIBA 05/2014
1	Adenosine Triphosphate (ATP)IBA 05/2014
1	HMGB1 Protein (HMG1)IBA 05/2014
1	AntigensIBA 01/2014
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2013
1	LuciferasesIBA 09/2013
1	IntegrinsIBA 04/2012
1	Interleukin-6 (Interleukin 6)IBA 10/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011
1	Biological ProductsIBA 10/2011
1	7-hydroxystaurosporine (UCN 01)IBA 10/2010

Therapy/Procedure

28	Therapeutics 10/2021 - 05/2002
11	Oncolytic Virotherapy 01/2019 - 08/2010
5	Drug Therapy (Chemotherapy) 08/2017 - 02/2011
4	Immunotherapy 01/2021 - 01/2015
3	Radiotherapy 02/2016 - 06/2007
3	Injections 02/2015 - 03/2007
2	Intravenous Infusions 12/2017 - 08/2017
1	Aftercare (After-Treatment) 12/2017
1	Investigational Therapies (Experimental Therapy) 01/2015
1	Intravenous Injections 01/2014